Publication | Closed Access

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

Open-label Extension StudySystemic TreatmentSevere PsoriasisClinical TrialsTreatment OptionClinical DermatologyDermatologyMedicineClinical Response